Global Oncology Drug Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Oncology Drug

• 1.1 Definition of Oncology Drug
• 1.2 Oncology Drug Segment by Type
  • 1.2.1 Global Oncology Drug Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Chemotherapy
  • 1.2.3 Targeted Therapy
  • 1.2.4 Immunotherapy
  • 1.2.5 Hormonal Therapy
  • 1.2.6 Others
• 1.3 Oncology Drug Segment by Applications
  • 1.3.1 Global Oncology Drug Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Blood Cancer
  • 1.3.3 Breast Cancer
  • 1.3.4 gastrointestinal Tract Cancer
  • 1.3.5 Prostate Cancer
  • 1.3.6 Lung Cancer
  • 1.3.7 Skin Cancer
• 1.4 Global Oncology Drug Overall Market
  • 1.4.1 Global Oncology Drug Revenue (2014-2025)
  • 1.4.2 Global Oncology Drug Production (2014-2025)
  • 1.4.3 North America Oncology Drug Status and Prospect (2014-2025)
  • 1.4.4 Europe Oncology Drug Status and Prospect (2014-2025)
  • 1.4.5 China Oncology Drug Status and Prospect (2014-2025)
  • 1.4.6 Japan Oncology Drug Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Oncology Drug Status and Prospect (2014-2025)
  • 1.4.8 India Oncology Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Oncology Drug
• 2.3 Manufacturing Process Analysis of Oncology Drug
• 2.4 Industry Chain Structure of Oncology Drug

3 Development and Manufacturing Plants Analysis of Oncology Drug

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Oncology Drug Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Oncology Drug
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Oncology Drug Production and Capacity Analysis
• 4.2 Oncology Drug Revenue Analysis
• 4.3 Oncology Drug Price Analysis
• 4.4 Market Concentration Degree

5 Oncology Drug Regional Market Analysis

• 5.1 Oncology Drug Production by Regions
  • 5.1.1 Global Oncology Drug Production by Regions
  • 5.1.2 Global Oncology Drug Revenue by Regions
• 5.2 Oncology Drug Consumption by Regions
• 5.3 North America Oncology Drug Market Analysis
  • 5.3.1 North America Oncology Drug Production
  • 5.3.2 North America Oncology Drug Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Oncology Drug Import and Export
• 5.4 Europe Oncology Drug Market Analysis
  • 5.4.1 Europe Oncology Drug Production
  • 5.4.2 Europe Oncology Drug Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Oncology Drug Import and Export
• 5.5 China Oncology Drug Market Analysis
  • 5.5.1 China Oncology Drug Production
  • 5.5.2 China Oncology Drug Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Oncology Drug Import and Export
• 5.6 Japan Oncology Drug Market Analysis
  • 5.6.1 Japan Oncology Drug Production
  • 5.6.2 Japan Oncology Drug Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Oncology Drug Import and Export
• 5.7 Southeast Asia Oncology Drug Market Analysis
  • 5.7.1 Southeast Asia Oncology Drug Production
  • 5.7.2 Southeast Asia Oncology Drug Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Oncology Drug Import and Export
• 5.8 India Oncology Drug Market Analysis
  • 5.8.1 India Oncology Drug Production
  • 5.8.2 India Oncology Drug Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Oncology Drug Import and Export

6 Oncology Drug Segment Market Analysis (by Type)

• 6.1 Global Oncology Drug Production by Type
• 6.2 Global Oncology Drug Revenue by Type
• 6.3 Oncology Drug Price by Type

7 Oncology Drug Segment Market Analysis (by Application)

• 7.1 Global Oncology Drug Consumption by Application
• 7.2 Global Oncology Drug Consumption Market Share by Application (2014-2019)

8 Oncology Drug Major Manufacturers Analysis

• 8.1 Roche Ltd
  • 8.1.1 Roche Ltd Oncology Drug Production Sites and Area Served
  • 8.1.2 Roche Ltd Product Introduction, Application and Specification
  • 8.1.3 Roche Ltd Oncology Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Novartis AG
  • 8.2.1 Novartis AG Oncology Drug Production Sites and Area Served
  • 8.2.2 Novartis AG Product Introduction, Application and Specification
  • 8.2.3 Novartis AG Oncology Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Bristol-Myers Squibb
  • 8.3.1 Bristol-Myers Squibb Oncology Drug Production Sites and Area Served
  • 8.3.2 Bristol-Myers Squibb Product Introduction, Application and Specification
  • 8.3.3 Bristol-Myers Squibb Oncology Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Celgene Corporation
  • 8.4.1 Celgene Corporation Oncology Drug Production Sites and Area Served
  • 8.4.2 Celgene Corporation Product Introduction, Application and Specification
  • 8.4.3 Celgene Corporation Oncology Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Johnson & Johnson
  • 8.5.1 Johnson & Johnson Oncology Drug Production Sites and Area Served
  • 8.5.2 Johnson & Johnson Product Introduction, Application and Specification
  • 8.5.3 Johnson & Johnson Oncology Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Pfizer Inc.
  • 8.6.1 Pfizer Inc. Oncology Drug Production Sites and Area Served
  • 8.6.2 Pfizer Inc. Product Introduction, Application and Specification
  • 8.6.3 Pfizer Inc. Oncology Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Astra Zenca Plc
  • 8.7.1 Astra Zenca Plc Oncology Drug Production Sites and Area Served
  • 8.7.2 Astra Zenca Plc Product Introduction, Application and Specification
  • 8.7.3 Astra Zenca Plc Oncology Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Eli Lilly And Company.
  • 8.8.1 Eli Lilly And Company. Oncology Drug Production Sites and Area Served
  • 8.8.2 Eli Lilly And Company. Product Introduction, Application and Specification
  • 8.8.3 Eli Lilly And Company. Oncology Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Glaxosmithkline Plc
  • 8.9.1 Glaxosmithkline Plc Oncology Drug Production Sites and Area Served
  • 8.9.2 Glaxosmithkline Plc Product Introduction, Application and Specification
  • 8.9.3 Glaxosmithkline Plc Oncology Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Merck & Co.
  • 8.10.1 Merck & Co. Oncology Drug Production Sites and Area Served
  • 8.10.2 Merck & Co. Product Introduction, Application and Specification
  • 8.10.3 Merck & Co. Oncology Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Sanofi
• 8.12 Amgen Inc.
• 8.13 Abbvie

9 Development Trend of Analysis of Oncology Drug Market

• 9.1 Global Oncology Drug Market Trend Analysis
  • 9.1.1 Global Oncology Drug Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Oncology Drug Regional Market Trend
  • 9.2.1 North America Oncology Drug Forecast 2019-2025
  • 9.2.2 Europe Oncology Drug Forecast 2019-2025
  • 9.2.3 China Oncology Drug Forecast 2019-2025
  • 9.2.4 Japan Oncology Drug Forecast 2019-2025
  • 9.2.5 Southeast Asia Oncology Drug Forecast 2019-2025
  • 9.2.6 India Oncology Drug Forecast 2019-2025
• 9.3 Oncology Drug Market Trend (Product Type)
• 9.4 Oncology Drug Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Oncology Drug Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List